North America Biosimilars Market Size, Share, Forecast, and Growth Opportunity
North America biosimilars market is expected to grow by 25.1% annually in the forecast period and reach $27.57 billion by 2030 driven by the affordability of biosimilar-based treatment, rising incidence of chronic diseases due to aging populations, patent expirations of many blockbuster drugs, and better healthcare provisions.Highlighted with 29 tables and 54 figures, this 116-page … Read more